Stephen Barker
Stock Analyst at Jefferies
(3.76)
# 2,017
Out of 5,055 analysts
121
Total ratings
46%
Success rate
10.1%
Average return
Main Sectors:
Stocks Rated by Stephen Barker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4543 Terumo Corporation | Reiterated: Buy | ¥3,500 → ¥2,700 | ¥2,283 | +18.27% | 5 | Oct 9, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Reiterated: Hold | ¥8,000 → ¥6,100 | ¥6,235 | -2.17% | 9 | Sep 29, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Reiterated: Buy | ¥2,400 → ¥2,700 | ¥1,740 | +55.22% | 11 | Sep 14, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Hold | ¥2,800 → ¥2,600 | ¥2,285 | +13.81% | 6 | Sep 8, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Reiterated: Buy | ¥12,700 → ¥14,000 | ¥11,890 | +17.75% | 13 | Sep 7, 2026 | |
| TYO: 6869 Sysmex Corporation | Reiterated: Hold | ¥1,700 → ¥2,100 | ¥1,845 | +13.85% | 5 | Aug 27, 2026 | |
| TYO: 7733 Olympus Corporation | Reiterated: Buy | ¥2,300 → ¥3,300 | ¥1,746 | +89.06% | 5 | Aug 27, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Reiterated: Buy | ¥6,800 → ¥7,100 | ¥6,084 | +16.70% | 6 | Aug 21, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Downgraded: Hold | ¥3,100 → ¥3,000 | ¥2,650 | +13.23% | 14 | Jul 30, 2026 | |
| TYO: 2160 GNI Group Ltd. | Reiterated: Buy | ¥3,800 | ¥2,881 | +31.90% | 4 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,800 → ¥2,500 | ¥2,323 | +7.62% | 3 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥4,200 → ¥4,500 | ¥3,429 | +31.23% | 8 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥5,000 → ¥4,000 | ¥4,806 | -16.77% | 9 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥1,500 | ¥1,365 | +9.89% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥1,500 → ¥2,800 | ¥2,324 | +20.51% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥1,900 → ¥1,700 | ¥1,701 | n/a | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥7,400 → ¥2,500 | ¥2,860 | n/a | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,400 → ¥4,100 | ¥3,343 | n/a | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥560 → ¥660 | ¥536 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ¥320 | ¥287 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥2,700 | ¥1,045 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥3,600 | ¥3,770 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $639.60 | n/a | 1 | Feb 1, 2019 |
Terumo Corporation
Oct 9, 2026
Reiterated: Buy
Price Target: ¥3,500 → ¥2,700
Current: ¥2,283
Upside: +18.27%
Chugai Pharmaceutical Co., Ltd.
Sep 29, 2026
Reiterated: Hold
Price Target: ¥8,000 → ¥6,100
Current: ¥6,235
Upside: -2.17%
Sumitomo Pharma Co., Ltd.
Sep 14, 2026
Reiterated: Buy
Price Target: ¥2,400 → ¥2,700
Current: ¥1,740
Upside: +55.22%
Kyowa Kirin Co., Ltd.
Sep 8, 2026
Downgraded: Hold
Price Target: ¥2,800 → ¥2,600
Current: ¥2,285
Upside: +13.81%
Otsuka Holdings Co., Ltd.
Sep 7, 2026
Reiterated: Buy
Price Target: ¥12,700 → ¥14,000
Current: ¥11,890
Upside: +17.75%
Sysmex Corporation
Aug 27, 2026
Reiterated: Hold
Price Target: ¥1,700 → ¥2,100
Current: ¥1,845
Upside: +13.85%
Olympus Corporation
Aug 27, 2026
Reiterated: Buy
Price Target: ¥2,300 → ¥3,300
Current: ¥1,746
Upside: +89.06%
Takeda Pharmaceutical Company Limited
Aug 21, 2026
Reiterated: Buy
Price Target: ¥6,800 → ¥7,100
Current: ¥6,084
Upside: +16.70%
Daiichi Sankyo Company, Limited
Jul 30, 2026
Downgraded: Hold
Price Target: ¥3,100 → ¥3,000
Current: ¥2,650
Upside: +13.23%
GNI Group Ltd.
Jul 13, 2026
Reiterated: Buy
Price Target: ¥3,800
Current: ¥2,881
Upside: +31.90%
May 29, 2026
Reiterated: Hold
Price Target: ¥1,800 → ¥2,500
Current: ¥2,323
Upside: +7.62%
May 29, 2026
Reiterated: Buy
Price Target: ¥4,200 → ¥4,500
Current: ¥3,429
Upside: +31.23%
May 28, 2026
Reiterated: Hold
Price Target: ¥5,000 → ¥4,000
Current: ¥4,806
Upside: -16.77%
Apr 30, 2026
Reiterated: Hold
Price Target: ¥1,500
Current: ¥1,365
Upside: +9.89%
Mar 24, 2026
Reiterated: Buy
Price Target: ¥1,500 → ¥2,800
Current: ¥2,324
Upside: +20.51%
Aug 8, 2025
Downgraded: Hold
Price Target: ¥1,900 → ¥1,700
Current: ¥1,701
Upside: n/a
Oct 25, 2024
Reiterated: Hold
Price Target: ¥7,400 → ¥2,500
Current: ¥2,860
Upside: n/a
Oct 21, 2024
Reiterated: Hold
Price Target: ¥3,400 → ¥4,100
Current: ¥3,343
Upside: n/a
Sep 11, 2024
Reiterated: Hold
Price Target: ¥560 → ¥660
Current: ¥536
Upside: n/a
Sep 9, 2024
Upgraded: Buy
Price Target: ¥320
Current: ¥287
Upside: n/a
Aug 1, 2024
Reiterated: Hold
Price Target: ¥2,700
Current: ¥1,045
Upside: n/a
Jul 30, 2024
Reiterated: Hold
Price Target: ¥3,600
Current: ¥3,770
Upside: n/a
Feb 1, 2019
Upgraded: Buy
Price Target: n/a
Current: $639.60
Upside: n/a